What's new

Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Apr 25, 2025 - 16:40
 0
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Piasky, Crovalimab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, D...

Next Article

Vivienne Westwood brings punk flair to Barcelona Bridal Fashion Week

Related Posts

Assessment templates and guidance

Assessment templates and guidance

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Herbal medicinal product: Hamamelidis folium, Hamamelis virginiana L., F: Assessment finalised

Herbal medicinal product: Hamamelidis folium, Hamamelis...

Apr 1, 2025  0